acquisition costs have more than doubled in the past few years
and will continue to rise as blood production costs increase and
the supply struggles to meet the demand. But that’s just
the tip of the iceberg. Factor in other costs, like labor, supplies
and blood administration, to name a few, and the price tag for
transfusing patients exceeds blood-acquisition costs by five times
utilization has become a major focus in the U.S. In addition to
escalating costs and more frequent shortages, there are growing
concerns about patient safety, risk management and medical-legal
liability for transfusion therapy. In fact, new evidence about
transfusion therapy suggests that, in general, the risks of transfusion
have been underestimated and the benefits overestimated. This
has lead to an imbalance in risk-benefit decisions—and new
blood-management performance measures from the Joint Commission.
what is your hospital doing to better manage its blood supply?
How can you meet the ever-increasing demand for blood while
keeping a lid on rising costs? And what steps can you take to
increase the safety of your patients while minimizing the risk
to your facility?
Get answers to these questions and more when you register to attend
the latest DARK REPORT and DARKDAILY.COM audio conference “Transfusion
& Blood Management: Practical Advice on How to Save Blood,
Save Dollars and Save Lives” was
on Wednesday, May 19, 2010.
to Live Recordings as two experts on blood management provide
you with information on an evidence-based, multidisciplinary
approach to blood utilization that promotes the safe and optimal
use of blood and its associated resources. First you’ll
hear from Dr. Tim Hannon, President and CEO of Strategic Healthcare
Group LLC. He’ll provide an environmental overview of
the push for better blood utilization, as well as a general
approach to establishing blood management programs.
get a real-world example of what happened when one major academic
medical center implemented a blood management program. Dr. Marisa
B. Marques, Professor of Pathology at the University of Alabama
at Birmingham Hospital will explain how their new blood management
program helped them reduce blood use by 29% and save $3.5M in
blood costs in only three years.
Whether you’re a hospital administrator, lab director, blood
bank supervisor or medical director—or anyone interested
in promoting safe and effective blood utilization practices—this
is one conference you won’t want to miss.
CD for this audio conference and get the most current information
about the benefits of blood management programs. Find out how
a multidisciplinary approach to changing institutional blood utilization
practice will improve quality, safety and stewardship of your
DARK REPORT AUDIO CONFERENCE RECORDING AT A GLANCE
Wednesday, May 19, 2010
COST: $245 per recording
TO ORDER CD:Click
here or call 1-800-560-6363 toll-free
one low price—just $245—you and your entire
team can take part in this fast-paced, insightful audio conference.
Here's just some of what you’ll learn during this in-depth
key issues driving the need for better blood utilization.
definition and history of blood management.
evidence behind a more conservative transfusion practice.
challenges of implementing a blood management program.
critical elements of a successful blood management program.
a blood management program can reduce blood use and save you
to Order CDs:
2. Call toll free: 800-560-6363.
audio conference order includes:
PowerPoint presentations from our speakers
full transcript emailed to you soon after the conference
Now!Or for more
information, call us toll-free at 800-560-6363.
Hannon, MD, MBA is President and CEO of Strategic
Healthcare Group LLC, a healthcare consulting group
that specializes in safe, efficient and effective blood
management solutions. He is a board certified anesthesiologist
who serves as medical director of the St. Vincent Indianapolis
Blood Management Program that he designed and implemented
in 2001. Since its establishment, the blood management
program has reduced hospital transfusions by more than
30%, resulting in annual savings of more than 7,000
units of blood products and cost savings that exceed
$4 million per year. Dr. Hannon was Director of Perioperative
Blood Conservation at the Naval Medical Center in San
Diego and the Director of Research for the Department
of Anesthesiology. He is a member of the Blood Utilization,
Quality Management and Audit Committees at St. Vincent
Hospital Indianapolis, and serves on several state and
national committees, including the AABB Perioperative
Standards Committee, the Medical Advisory Panel for
the Indiana Blood Center and the Indiana State Association
of Blood Bank, where he was president. He has lectured
extensively and published several peer-reviewed articles
and book chapters on perioperative blood management,
evidence-based guideline implementation and blood management
economics. Dr. Hannon graduated magna cum laude in biology
at the University of Evansville. He completed his doctor
of medicine at the Indiana University School of Medicine
where he received the Marcus Ravdin Medal for scholastic
B. Marques, MD is Professor of Pathology for
the University of Alabama at Birmingham Hospital. She
is certified by the American Board of Pathology in Anatomic
and Clinical Pathology, with subspecialties in Transfusion
Medicine/Blood Banking and Hematopathology. Dr. Marques’
academic career started at the University of Alabama
at Birmingham (UAB) in 1998, where she is the medical
director of Transfusion Service and Coagulation Service.
In these capacities, she provides consultation on proper
evaluation and management of patients with hemostasis
disorders, including the use of blood component therapy
in bleeding patients. Dr. Marques received her MD from
the Federal University of Rio Grande do Sul in Brazil.
Continuing Education Credit
The American Association of Clinical Chemistry (AACC) designates
this program for a maximum of 1.5 ACCENT® credit hours towards
the AACC Clinical Chemist’s Recognition Award. AACC is an
approved provider of continuing education for clinical laboratory
scientists in the states of California, Florida, Louisiana, Montana,
Nevada, North Dakota, Rhode Island, and West Virginia.